Profile
Sector:
HealthcareCountry:
AustraliaIPO:
02 March 2022Website:
http://www.incannex.com.auNext earnings report:
26 July 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | 22 min agoDividend
Analysts recommendations
Institutional Ownership
IXHL Latest News
NEW YORK and MELBOURNE, Australia, May 30, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (‘Incannex' or the ‘Company'), a pharmaceutical company developing unique medicinal cannabinoid pharmacotherapies and psychedelic medicine therapies is pleased to announce that patient dosing has commenced in the Company's Phase 2/3 clinical trial to assess safety and efficacy of IHL-42X in patients with obstructive sleep apnea (‘OSA').
What type of business is Incannex Healthcare Limited?
Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury; and IHL-675A, a combination of hydroxychloroquine and cannabidiol for the prevention and treatment of inflammatory lung conditions, such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and bronchitis, as well as rheumatoid arthritis and inflammatory bowel diseases. It has partnership with The Alfred Hospital and Novotech on IHL-42X clinical program for obstructive sleep apnea; and Monash Trauma Group at the Department of Neuroscience, Monash University to conduct a study on the protective effect of IHL-216A in sports concussion. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited was incorporated in 2001 and is based in Sydney, Australia.
What sector is Incannex Healthcare Limited in?
Incannex Healthcare Limited is in the Healthcare sector
What industry is Incannex Healthcare Limited in?
Incannex Healthcare Limited is in the Drug Manufacturers - Specialty & Generic industry
What country is Incannex Healthcare Limited from?
Incannex Healthcare Limited is headquartered in Australia
When did Incannex Healthcare Limited go public?
Incannex Healthcare Limited initial public offering (IPO) was on 02 March 2022
What is Incannex Healthcare Limited website?
https://www.incannex.com.au
Is Incannex Healthcare Limited in the S&P 500?
No, Incannex Healthcare Limited is not included in the S&P 500 index
Is Incannex Healthcare Limited in the NASDAQ 100?
No, Incannex Healthcare Limited is not included in the NASDAQ 100 index
Is Incannex Healthcare Limited in the Dow Jones?
No, Incannex Healthcare Limited is not included in the Dow Jones index
When does Incannex Healthcare Limited report earnings?
The next expected earnings date for Incannex Healthcare Limited is 26 July 2024